Quantum Biopharma Ltd (QNTM)

Nov 08, 2024

Quantum BioPharma Ltd expected to post a loss of $3.90 a shareEarnings Preview - XM

Nov 08, 2024

Oct 30, 2024

Quantum BioPharma initiates phase 1 multiple sclerosis trial By Investing.com - Investing.com Canada

Oct 30, 2024

Oct 29, 2024

Quantum BioPharma sues CIBC and RBC seeking $700M in damages - MSN

Oct 29, 2024

Oct 29, 2024

Quantum BioPharma initiates phase 1 multiple sclerosis trial - Investing.com

Oct 29, 2024

Oct 29, 2024

Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia - AccessWire

Oct 29, 2024

Oct 28, 2024

InvestmentPitch Media Video Discusses FSD Pharma's New OTCQB Symbol and Appointment of Former U.S. Congressman Stephen Buyer to its Board of DirectorsVideo Available on Investmentpitch.com - Marketscreener.com

Oct 28, 2024

Oct 28, 2024

Christian Attar Files Market Manipulation Case On Behalf of Quantum Biopharma - Marketscreener.com

Oct 28, 2024

Oct 23, 2024

Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum Biopharma - PR Newswire

Oct 23, 2024

Oct 22, 2024

Quantum BioPharma Ltd - Stockhouse Publishing

Oct 22, 2024

Oct 22, 2024

FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH - Marketscreener.com

Oct 22, 2024

Oct 22, 2024

Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spo - AccessWire

Oct 22, 2024

Oct 22, 2024

Quantum BioPharma posts link to lawsuit against CIBC World Markets, RBC Dominion - TipRanks

Oct 22, 2024

Oct 21, 2024

Quantum BioPharma alleges major market manipulation By Investing.com - Investing.com Australia

Oct 21, 2024

Oct 21, 2024

Quantum BioPharma sues over alleged stock spoofing - The Globe and Mail

Oct 21, 2024

Oct 21, 2024

Quantum BioPharma sues CIBC and RBC seeking $700M in damages | 2024-10-21 | Investing News - Stockhouse Publishing

Oct 21, 2024

Oct 21, 2024

Quantum BioPharma alleges major market manipulation - Investing.com

Oct 21, 2024

Oct 21, 2024

Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing - Chronicle-Tribune

Oct 21, 2024

Oct 21, 2024

Quantum BioPharma (QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700M - StreetInsider.com

Oct 21, 2024

Oct 15, 2024

Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd - openPR

Oct 15, 2024

Oct 15, 2024

Kairos Pharma (NYSEAmerican: KAPA): Advancing New Strategies to Overcome Cancer Treatment Challenges - openPR

Oct 15, 2024

Oct 15, 2024

Quantum BioPharma Expands Market for Alcohol Metabolism Product Unbuzzd - Citybuzz

Oct 15, 2024

Oct 07, 2024

Celly Nu secures distribution for alcohol metabolism drink By Investing.com - Investing.com South Africa

Oct 07, 2024

Oct 07, 2024

Celly Nu secures distribution deal in the Caribbean By Investing.com - Investing.com South Africa

Oct 07, 2024

Oct 07, 2024

Celly Nu secures distribution deal in the Caribbean - Investing.com India

Oct 07, 2024

Oct 07, 2024

Celly Nu secures distribution for alcohol metabolism drink - Investing.com

Oct 07, 2024

Oct 07, 2024

Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and Parts of Central and South America - Newsfile

Oct 07, 2024

Oct 07, 2024

Quantum BioPharma Ltd. Pharma Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group Across Puerto Rico, the Caribbean, and Parts of Central and South America - WSIL TV

Oct 07, 2024

Oct 07, 2024

Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and parts of Central and South America - AccessWire

Oct 07, 2024

Oct 04, 2024

Pre-market Movers: ALZN, VRAX, APDN, LQDA... - RTTNews

Oct 04, 2024

Sep 28, 2024

Quantum Biopharma Provides Corporate Update - GuruFocus.com

Sep 28, 2024

Sep 25, 2024

Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US - Markets Insider

Sep 25, 2024

Sep 25, 2024

Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Invesments and Kingswood US - Quantisnow

Sep 25, 2024

Sep 24, 2024

Investor.News Prepares for the ArcStone-Kingswood Growth Summit 2024 - InvestorNews Inc.

Sep 24, 2024

Sep 13, 2024

Quantum BioPharma Closes Private Placement Offering - Invezz

Sep 13, 2024

Sep 13, 2024

QUANTUM BIOPHAR (QNTM) Upgraded to Buy: Here's What You Should Know - MSN

Sep 13, 2024

Sep 12, 2024

Quantum BioPharma Ltd. announced that it has received CAD 0.000036 million in funding from Fortius Research and Trading Corporation, Xorax Family Trust - Marketscreener.com

Sep 12, 2024

Sep 10, 2024

Quantum BioPharma to run multiple sclerosis progression study | 2024-09-09 | Investing News - Stockhouse Publishing

Sep 10, 2024

Sep 10, 2024

Quantum BioPharma partners for multiple sclerosis study - Investing.com

Sep 10, 2024

Sep 09, 2024

S&P 500 Materials [Sector] (SRMA) QuotePress Release - The Globe and Mail

Sep 09, 2024

Sep 09, 2024

Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis - Digital Journal

Sep 09, 2024

Sep 09, 2024

Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease - PharmiWeb.com

Sep 09, 2024